EDUCATION

Undergraduate Degree

  • Union College , 1990 , Lincoln , NE

Medical School

  • Loma Linda University School of Medicine , 1994 , Loma Linda , CA

Residency

  • Children's Hospital of Los Angeles , 1997 , Los Angeles , CA

Fellowship

  • Johns Hopkins University , 2000 , Baltimore , MD

Graduate Degree

  • Harvard School of Public Health , 2004 , Boston , MA

CERTIFICATIONS

  • American Board of Allergy and Immunology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Pneumonia in Infancy and Risk for Asthma: Examining the Role of How Viruses Impact Asthma and Potential Interventions. Chest. 2021 Aug; 160(2):385-386. View abstract
  2. Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels. Eur Respir J. 2021 Jul 29. View abstract
  3. Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy. Contemp Clin Trials. 2021 Jul 16; 108:106510. View abstract
  4. Predictors of successful mouse allergen reduction in inner-city homes of children with asthma. J Allergy Clin Immunol Pract. 2021 Jul 12. View abstract
  5. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank. BMJ Open. 2021 07 02; 11(7):e048338. View abstract
  6. A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care. Eur Respir J. 2021 07; 58(1). View abstract
  7. Detection of Food Allergens in School and Home Environments of Elementary Students. J Allergy Clin Immunol Pract. 2021 Jun 24. View abstract
  8. Inhaled Corticosteroid Use in Early Childhood: A Risk for High BMI? Am J Respir Crit Care Med. 2021 Jun 23. View abstract
  9. Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels. J Allergy Clin Immunol. 2021 Jun 09. View abstract
  10. Associations of Snoring and Asthma Morbidity in the School Inner-City Asthma Study. J Allergy Clin Immunol Pract. 2021 Jun 06. View abstract
  11. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jun; 22(6):794-795. View abstract
  12. Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic. BMJ Open Respir Res. 2021 06; 8(1). View abstract
  13. Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma. Am J Respir Crit Care Med. 2021 04 01; 203(7):841-852. View abstract
  14. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection. Am J Respir Crit Care Med. 2021 04 01; 203(7):822-830. View abstract
  15. Isolation and characterization of extracellular vesicles in saliva of children with asthma. Extracell Vesicles Circ Nucl Acids. 2021; 2:29-48. View abstract
  16. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. Allergy. 2021 06; 76(6):1765-1775. View abstract
  17. The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years. J Allergy Clin Immunol Pract. 2021 07; 9(7):2916-2919.e2. View abstract
  18. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design. medRxiv. 2021 Mar 20. View abstract
  19. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment. J Allergy Clin Immunol. 2021 May; 147(5):1594-1601. View abstract
  20. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect. J Allergy Clin Immunol Pract. 2021 03; 9(3):1053-1065. View abstract
  21. Adherence rates during a randomized controlled trial evaluating the use of blinded acetaminophen and ibuprofen in children with asthma. Contemp Clin Trials. 2021 05; 104:106334. View abstract
  22. Association of step count with PROMIS pediatric health-related quality of life measures in children and adolescents with persistent asthma. J Allergy Clin Immunol Pract. 2021 06; 9(6):2492-2494. View abstract
  23. Geography, generalisability, and susceptibility in clinical trials. Lancet Respir Med. 2021 04; 9(4):330-332. View abstract
  24. The evolution of food protein-induced enterocolitis syndrome: From a diagnosis that did not exist to a condition in need of answers. Ann Allergy Asthma Immunol. 2021 05; 126(5):489-497. View abstract
  25. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jan; 22(1):100. View abstract
  26. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021 01; 100:106228. View abstract
  27. Predicting outcomes of baked egg and baked milk oral food challenges by using a ratio of food-specific IgE to total IgE. J Allergy Clin Immunol Pract. 2021 04; 9(4):1750-1752.e1. View abstract
  28. The United States' reckoning with racism during the COVID-19 pandemic: What can we learn and do as allergist-immunologists? J Allergy Clin Immunol. 2021 02; 147(2):504-506. View abstract
  29. Asthma Prevalence and Mold Levels in US Northeastern Schools. J Allergy Clin Immunol Pract. 2021 03; 9(3):1312-1318. View abstract
  30. Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency. Am J Respir Crit Care Med. 2020 10 01; 202(7):973-982. View abstract
  31. Editorial overview: Allergy and hypersensitivity - an introduction from the editors. Curr Opin Immunol. 2020 10; 66:vi-viii. View abstract
  32. Screening Social Determinants of Health in a Multidisciplinary Severe Asthma Clinical Program. Pediatr Qual Saf. 2020 Sep-Oct; 5(5):e360. View abstract
  33. The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. J Biopharm Stat. 2020 11 01; 30(6):1026-1037. View abstract
  34. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2020 11; 21(11):1359-1370. View abstract
  35. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. JAMA. 2020 08 25; 324(8):752-760. View abstract
  36. Maternal Distress and Allergic Disease: Early Childhood Stressors Shape Long-Term Health. Chest. 2020 07; 158(1):5-6. View abstract
  37. The Psychosocial Impact of Food Protein-Induced Enterocolitis Syndrome. J Allergy Clin Immunol Pract. 2020 Nov - Dec; 8(10):3508-3514.e5. View abstract
  38. The efficacy of a novel monitoring device on asthma control in children with asthma. Ann Allergy Asthma Immunol. 2020 09; 125(3):352-354. View abstract
  39. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 09; 8(8):2592-2599.e3. View abstract
  40. The Indoor Environment and Childhood Asthma. Curr Allergy Asthma Rep. 2020 06 16; 20(9):43. View abstract
  41. Risk of physician burnout in the North American allergist-immunologist workforce: A report from the American College of Allergy, Asthma and Immunology Physician Wellness Taskforce. Ann Allergy Asthma Immunol. 2020 09; 125(3):235-243. View abstract
  42. Impact of DNA Extraction Method on Variation in Human and Built Environment Microbial Community and Functional Profiles Assessed by Shotgun Metagenomics Sequencing. Front Microbiol. 2020; 11:953. View abstract
  43. Differential Effect of School-Based Pollution Exposure in Children With Asthma Born Prematurely. Chest. 2020 10; 158(4):1361-1363. View abstract
  44. Prevention of Asthma: Targets for Intervention. Chest. 2020 09; 158(3):913-922. View abstract
  45. Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children. J Allergy Clin Immunol. 2020 10; 146(4):813-820.e2. View abstract
  46. Heterogeneity of Mild to Moderate Persistent Asthma in Children: Confirmation by Latent Class Analysis and Association with 1-Year Outcomes. J Allergy Clin Immunol Pract. 2020 09; 8(8):2617-2627.e4. View abstract
  47. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank. J Allergy Clin Immunol Pract. 2020 06; 8(6):1953-1960.e9. View abstract
  48. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020 02; 8(2):429-440. View abstract
  49. A Slice of Food Protein-Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association. J Allergy Clin Immunol Pract. 2020 05; 8(5):1702-1709. View abstract
  50. Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy. Pediatr Pulmonol. 2020 03; 55(3):580-590. View abstract
  51. Reduction in mouse allergen exposure is associated with greater lung function growth. J Allergy Clin Immunol. 2020 02; 145(2):646-653.e1. View abstract
  52. The upper-airway microbiota and loss of asthma control among asthmatic children. Nat Commun. 2019 12 16; 10(1):5714. View abstract
  53. Asthma and Allergies in the School Environment. Clin Rev Allergy Immunol. 2019 Dec; 57(3):415-426. View abstract
  54. Nature and nurture: Lifelong consequences of environmental exposures. Ann Allergy Asthma Immunol. 2019 12; 123(6):532-533. View abstract
  55. The Impact of Ambient Environmental Exposures to Microbial Products on Asthma Outcomes from Birth to Childhood. Curr Allergy Asthma Rep. 2019 11 28; 19(12):59. View abstract
  56. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol. 2020 03; 145(3):897-906. View abstract
  57. Severe asthma during childhood and adolescence: A longitudinal study. J Allergy Clin Immunol. 2020 01; 145(1):140-146.e9. View abstract
  58. Development and initial validation of the Asthma Severity Scoring System (ASSESS). J Allergy Clin Immunol. 2020 01; 145(1):127-139. View abstract
  59. Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician. World Allergy Organ J. 2019 Sep; 12(9):100054. View abstract
  60. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019 09 26; 381(13):1227-1239. View abstract
  61. Proximity to major roadways and asthma symptoms in the School Inner-City Asthma Study. J Allergy Clin Immunol. 2020 01; 145(1):119-126.e4. View abstract
  62. Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction? J Allergy Clin Immunol Pract. 2020 02; 8(2):596-602.e3. View abstract
  63. Exacerbation-prone asthma in the context of race and ancestry in Asthma Clinical Research Network trials. J Allergy Clin Immunol. 2019 12; 144(6):1524-1533. View abstract
  64. Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma. J Allergy Clin Immunol. 2020 01; 145(1):430-433. View abstract
  65. Clinical significance of the bronchodilator response in children with severe asthma. Pediatr Pulmonol. 2019 11; 54(11):1694-1703. View abstract
  66. Racial and socioeconomic differences in school peanut-free policies. J Allergy Clin Immunol Pract. 2020 01; 8(1):340-342.e1. View abstract
  67. Deficits and opportunities in allergists' approaches to food allergy-related bullying. J Allergy Clin Immunol Pract. 2020 01; 8(1):343-345.e2. View abstract
  68. Classroom indoor PM2.5 sources and exposures in inner-city schools. Environ Int. 2019 10; 131:104968. View abstract
  69. Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. Am J Respir Crit Care Med. 2019 06 01; 199(11):1358-1367. View abstract
  70. Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. N Engl J Med. 2019 05 23; 380(21):2009-2019. View abstract
  71. The Effects of the Environment on Asthma Disease Activity. Immunol Allergy Clin North Am. 2019 05; 39(2):163-175. View abstract
  72. Preventing the development of asthma: stopping the allergic march. Curr Opin Allergy Clin Immunol. 2019 04; 19(2):161-168. View abstract
  73. Building and indoor environmental quality assessment of Nigerian primary schools: A pilot study. Indoor Air. 2019 05; 29(3):510-520. View abstract
  74. Association between fungal spore exposure in inner-city schools and asthma morbidity. Ann Allergy Asthma Immunol. 2019 06; 122(6):610-615.e1. View abstract
  75. Treatment of severe persistent asthma with IL-6 receptor blockade. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1639-1642.e4. View abstract
  76. Use of a School-Based Survey to Screen Students for Symptoms Concerning for Asthma. Clin Pediatr (Phila). 2019 05; 58(5):586-589. View abstract
  77. Asthma and Corticosteroid Responses in Childhood and Adult Asthma. Clin Chest Med. 2019 03; 40(1):163-177. View abstract
  78. Caregiver-Reported Asthma Control Predicts Future Visits, Independent of Guideline-Based Control Measures. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1516-1521.e1. View abstract
  79. Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children. J Allergy Clin Immunol. 2019 05; 143(5):1934-1937.e4. View abstract
  80. Severe asthma in children: Evaluation and management. Allergol Int. 2019 Apr; 68(2):150-157. View abstract
  81. Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2019 06; 143(6):2052-2061. View abstract
  82. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document. Allergy. 2019 03; 74(3):449-463. View abstract
  83. Asthma in the melting pot. Ann Allergy Asthma Immunol. 2019 02; 122(2):136-139. View abstract
  84. Pediatric asthma: An unmet need for more effective, focused treatments. Pediatr Allergy Immunol. 2019 02; 30(1):7-16. View abstract
  85. Environmental Food Exposure: What Is the Risk of Clinical Reactivity From Cross-Contact and What Is the Risk of Sensitization. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):1825-1832. View abstract
  86. Validation of the maximum symptom day among children with asthma. J Allergy Clin Immunol. 2019 02; 143(2):803-805.e10. View abstract
  87. Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation. J Allergy Clin Immunol Pract. 2019 03; 7(3):915-924.e7. View abstract
  88. Bronchodilator Use for Acute Chest Syndrome Among Large Pediatric Hospitals in North America. Clin Pediatr (Phila). 2018 12; 57(14):1630-1637. View abstract
  89. Fluid Balance Is Associated with Clinical Outcomes and Extravascular Lung Water in Children with Acute Asthma Exacerbation. Am J Respir Crit Care Med. 2018 05 01; 197(9):1128-1135. View abstract
  90. School exposure and asthma. Ann Allergy Asthma Immunol. 2018 05; 120(5):482-487. View abstract
  91. Taming Asthma in School-Aged Children: A Comprehensive Review. J Allergy Clin Immunol Pract. 2018 May - Jun; 6(3):726-735. View abstract
  92. A Community-Based Pilot Survey of Pediatric Food Allergies in a Maryland Orthodox Jewish Community. Clin Pediatr (Phila). 2018 09; 57(10):1236-1238. View abstract
  93. Transcutaneous CO-oximetry differentiates asthma exacerbation and convalescence in children. J Allergy Clin Immunol. 2018 08; 142(2):676-678.e5. View abstract
  94. Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma. BMC Pulm Med. 2018 Apr 10; 18(1):58. View abstract
  95. The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma. Ann Allergy Asthma Immunol. 2018 06; 120(6):559-579.e11. View abstract
  96. The classroom microbiome and asthma morbidity in children attending 3 inner-city schools. J Allergy Clin Immunol. 2018 06; 141(6):2311-2313. View abstract
  97. Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation? J Allergy Clin Immunol. 2018 07; 142(1):308-311.e9. View abstract
  98. Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. N Engl J Med. 2018 Mar 08; 378(10):891-901. View abstract
  99. Gene-Environment Interactions Associated with the Severity of Acute Asthma Exacerbation in Children. Am J Respir Crit Care Med. 2018 03 01; 197(5):545-547. View abstract
  100. School Environmental Intervention Programs. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):22-29. View abstract
  101. Environmental Control: The First Tenet of Allergy. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):36-37. View abstract
  102. Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids. J Allergy Clin Immunol. 2018 04; 141(4):1459-1467.e2. View abstract
  103. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017 12; 50(6). View abstract
  104. School nurse asthma program reduces healthcare utilization in children with persistent asthma. J Asthma. 2018 10; 55(10):1131-1137. View abstract
  105. Advances in environmental and occupational disorders in 2016. J Allergy Clin Immunol. 2017 Dec; 140(6):1683-1692. View abstract
  106. Nitrogen dioxide exposure in school classrooms of inner-city children with asthma. J Allergy Clin Immunol. 2018 06; 141(6):2249-2255.e2. View abstract
  107. Gene-environment interaction between an IL4R variant and school endotoxin exposure contributes to asthma symptoms in inner-city children. J Allergy Clin Immunol. 2018 02; 141(2):794-796.e3. View abstract
  108. Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies. J Allergy Clin Immunol Pract. 2018 May - Jun; 6(3):907-915.e7. View abstract
  109. Managing Asthma in Low-Income, Underrepresented Minority, and Other Disadvantaged Pediatric Populations: Closing the Gap. Curr Allergy Asthma Rep. 2017 Sep 15; 17(10):68. View abstract
  110. Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):545-554.e4. View abstract
  111. Reply. J Allergy Clin Immunol. 2017 10; 140(4):1214-1215. View abstract
  112. Adherence and stress in a population of inner-city children with asthma. Pediatr Allergy Immunol. 2017 09; 28(6):610-612. View abstract
  113. Reply. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1165-1166. View abstract
  114. Distribution of peanut protein in school and home environments of inner-city children. J Allergy Clin Immunol. 2017 12; 140(6):1724-1726. View abstract
  115. The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned. Contemp Clin Trials. 2017 09; 60:14-23. View abstract
  116. Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma. Am J Respir Crit Care Med. 2017 06 01; 195(11):1439-1448. View abstract
  117. Income is an independent risk factor for worse asthma outcomes. J Allergy Clin Immunol. 2018 02; 141(2):754-760.e3. View abstract
  118. NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and management. J Allergy Clin Immunol. 2017 Oct; 140(4):933-949. View abstract
  119. Reduced mouse allergen is associated with epigenetic changes in regulatory genes, but not mouse sensitization, in asthmatic children. Environ Res. 2017 07; 156:619-624. View abstract
  120. Caregiver stress among inner-city school children with asthma. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1132-1134.e3. View abstract
  121. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017; 10(1):14. View abstract
  122. Impact of school peanut-free policies on epinephrine administration. J Allergy Clin Immunol. 2017 Aug; 140(2):465-473. View abstract
  123. Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma: A Randomized Clinical Trial. JAMA. 2017 03 14; 317(10):1027-1036. View abstract
  124. Reply. J Allergy Clin Immunol. 2017 05; 139(5):1717-1718. View abstract
  125. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations. Am J Respir Crit Care Med. 2017 02 01; 195(3):302-313. View abstract
  126. Environmental control measures for the management of atopy. Ann Allergy Asthma Immunol. 2017 02; 118(2):154-160. View abstract
  127. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1040-1049.e4. View abstract
  128. Race is associated with differences in airway inflammation in patients with asthma. J Allergy Clin Immunol. 2017 Jul; 140(1):257-265.e11. View abstract
  129. Association Between Allergen Exposure in Inner-City Schools and Asthma Morbidity Among Students. JAMA Pediatr. 2017 01 01; 171(1):31-38. View abstract
  130. The Calculated Risk of Childhood Asthma From Severe Bronchiolitis. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):97-98. View abstract
  131. Cross-Disciplinary Consultancy to Enhance Predictions of Asthma Exacerbation Risk in Boston. Online J Public Health Inform. 2016; 8(3):e199. View abstract
  132. Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation. Am J Respir Crit Care Med. 2016 12 15; 194(12):1552-1555. View abstract
  133. Mouse Sensitization and Exposure Are Associated with Asthma Severity in Urban Children. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1008-1014.e1. View abstract
  134. Indoor allergen exposure and asthma outcomes. Curr Opin Pediatr. 2016 12; 28(6):772-777. View abstract
  135. Acetaminophen versus Ibuprofen in Mild Persistent Asthma. N Engl J Med. 2016 11 24; 375(21):2099-100. View abstract
  136. Comparison of treatment modalities for inpatient asthma exacerbations among US pediatric hospitals. J Allergy Clin Immunol Pract. 2017 May - Jun; 5(3):855-857.e1. View abstract
  137. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016 12; 138(6):1608-1618.e12. View abstract
  138. School Environmental Intervention to Reduce Particulate Pollutant Exposures for Children with Asthma. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):154-159.e3. View abstract
  139. Modeling indoor particulate exposures in inner-city school classrooms. J Expo Sci Environ Epidemiol. 2017 09; 27(5):451-457. View abstract
  140. Creation and implementation of SAMPRO™: A school-based asthma management program. J Allergy Clin Immunol. 2016 Sep; 138(3):711-723. View abstract
  141. Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma. N Engl J Med. 2016 Aug 18; 375(7):619-30. View abstract
  142. An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells. Nat Med. 2016 09; 22(9):1013-22. View abstract
  143. Utility of a portable hand-held forced expiratory volume in 1 second meter for monitoring asthma in an inner-city school setting. Ann Allergy Asthma Immunol. 2016 09; 117(3):323-4. View abstract
  144. Pediatric Rhinosinusitis. Curr Treat Options Allergy. 2016 Sep; 3(3):268-281. View abstract
  145. Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies. Ann Allergy Asthma Immunol. 2016 07; 117(1):17-20. View abstract
  146. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol. 2016 11; 138(5):1467-1471.e9. View abstract
  147. Association of FEF25%-75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma. Ann Allergy Asthma Immunol. 2016 07; 117(1):97-9. View abstract
  148. Characterization of the bacterial and fungal microbiome in indoor dust and outdoor air samples: a pilot study. Environ Sci Process Impacts. 2016 Jun 15; 18(6):713-24. View abstract
  149. Atopy, but not obesity is associated with asthma severity among children with persistent asthma. J Asthma. 2016 12; 53(10):1033-44. View abstract
  150. Recent advances in environmental controls outside the home setting. Curr Opin Allergy Clin Immunol. 2016 Apr; 16(2):135-41. View abstract
  151. Procedures to Assist Health Care Providers to Determine When Home Assessments for Potential Mold Exposure Are Warranted. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):417-422.e2. View abstract
  152. Exposure and Health Effects of Fungi on Humans. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):396-404. View abstract
  153. An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol. 2016; 12(5):521-30. View abstract
  154. Early exposure to dogs and farm animals reduces risk of childhood asthma. Evid Based Med. 2016 Apr; 21(2):80. View abstract
  155. Clinical Evaluation and Management of Patients with Suspected Fungus Sensitivity. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):405-14. View abstract
  156. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. JAMA. 2015 Nov 17; 314(19):2034-2044. View abstract
  157. School Endotoxin Exposure and Asthma Morbidity in Inner-city Children. Chest. 2015 Nov; 148(5):1251-1258. View abstract
  158. The school environment and asthma in childhood. Asthma Res Pract. 2015; 1. View abstract
  159. Mouse Sensitivity is an Independent Risk Factor for Rhinitis in Children with Asthma. J Allergy Clin Immunol Pract. 2016 Jan-Feb; 4(1):82-8.e1. View abstract
  160. Difficult-to-control asthma: epidemiology and its link with environmental factors. Curr Opin Allergy Clin Immunol. 2015 Oct; 15(5):397-401. View abstract
  161. Alternate methods of nasal epithelial cell sampling for airway genomic studies. J Allergy Clin Immunol. 2015 Oct; 136(4):1120-3.e4. View abstract
  162. Black and Hispanic perceptions of asthma medication in the School Inner-City Asthma Study. Ann Allergy Asthma Immunol. 2015 Jun; 114(6):533-4. View abstract
  163. Year in review: pediatric allergy and asthma, excluding food allergy. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):175-7. View abstract
  164. Association between allergic sensitization and exhaled nitric oxide in children in the School Inner-City Asthma Study. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):256-257.e1. View abstract
  165. Effectiveness of a computer module to augment the training of school staff in the management of students with food allergies. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):254-255.e3. View abstract
  166. Child with atopic dermatitis. Ann Allergy Asthma Immunol. 2015 Jan; 114(1):6-11. View abstract
  167. Ovomucoid specific immunoglobulin E as a predictor of tolerance to cooked egg. Allergy Rhinol (Providence). 2015 Jan; 6(3):198-204. View abstract
  168. How mothers and fathers perceive childhood food allergies: comparing apples to oranges? Ann Allergy Asthma Immunol. 2015 Feb; 114(2):77-8. View abstract
  169. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents. Immunol Allergy Clin North Am. 2015 Feb; 35(1):129-44. View abstract
  170. Airway and systemic inflammation in obese children with asthma. Pediatrics. 2014 Nov; 134 Suppl 3:S169. View abstract
  171. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Pediatrics. 2014 Nov; 134 Suppl 3:S175-6. View abstract
  172. Add-on Omalizumab in Children With Severe Allergic Asthma: A 1-Year Real Life Survey. Pediatrics. 2014 Nov; 134 Suppl 3:S179-80. View abstract
  173. Introducing an environmental assessment and intervention program in inner-city schools. J Allergy Clin Immunol. 2014 Dec; 134(6):1232-1237. View abstract
  174. Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the Institute of Medicine. Environ Health Perspect. 2015 Jan; 123(1):6-20. View abstract
  175. Reprint of: Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis. Int Immunopharmacol. 2014 Nov; 23(1):337-46. View abstract
  176. Childhood asthma and obesity--what is the true link? Ann Allergy Asthma Immunol. 2014 Sep; 113(3):244-6. View abstract
  177. Perinatal and early childhood environmental factors influencing allergic asthma immunopathogenesis. Int Immunopharmacol. 2014 Sep; 22(1):21-30. View abstract
  178. The indoor environment and inner-city childhood asthma. Asian Pac J Allergy Immunol. 2014 Jun; 32(2):103-10. View abstract
  179. Social disadvantage and asthma control in children. Paediatr Respir Rev. 2014 Sep; 15(3):256-62; quiz 262-3. View abstract
  180. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May; 311(20):2083-91. View abstract
  181. Reply: To PMID 24290281. J Allergy Clin Immunol. 2014 Jun; 133(6):1776-7. View abstract
  182. Allergens on desktop surfaces in preschools and elementary schools of urban children with asthma. Allergy. 2014 Jul; 69(7):960-963. View abstract
  183. Intravenous ß agonists and severe pediatric asthma exacerbation: time for a closer look at terbutaline? Ann Allergy Asthma Immunol. 2014 Mar; 112(3):187. View abstract
  184. Environmental remediation in the treatment of allergy and asthma: latest updates. Curr Allergy Asthma Rep. 2014 Mar; 14(3):419. View abstract
  185. Characterization of tree allergy prevalence in children younger than 4 years. Ann Allergy Asthma Immunol. 2014 Apr; 112(4):388-9. View abstract
  186. Perceived neighborhood safety and asthma morbidity in the school inner-city asthma study. Pediatr Pulmonol. 2015 Jan; 50(1):17-24. View abstract
  187. ß-2 adrenergic receptor gene methylation is associated with decreased asthma severity in inner-city schoolchildren: asthma and rhinitis. Clin Exp Allergy. 2014; 44(5):681-9. View abstract
  188. Characterization of aeroallergen sensitivities in children with allergic rhinitis and chronic rhinosinusitis. Allergy Rhinol (Providence). 2014 Jan; 5(3):143-5. View abstract
  189. Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study. Receptors Clin Investig. 2014; 1(1). View abstract
  190. Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol. 2014 Feb; 78(2):343-7. View abstract
  191. Utility of the Asthma Predictive Index in predicting childhood asthma and identifying disease-modifying interventions. Ann Allergy Asthma Immunol. 2014 Mar; 112(3):188-90. View abstract
  192. Environmental assessment and exposure control of dust mites: a practice parameter. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):465-507. View abstract
  193. Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol. 2014 Jan; 133(1):3-13; quiz 14. View abstract
  194. Exposures to molds in school classrooms of children with asthma. Pediatr Allergy Immunol. 2013 Nov; 24(7):697-703. View abstract
  195. Atopy and the Development of Chronic Rhinosinusitis in Children with Allergic Rhinitis. J Allergy Clin Immunol Pract. 2013 Nov 01; 6(1):689-691.e2. View abstract
  196. Rethinking the prevalence of exercise-induced bronchoconstriction in patients with asthma. Ann Allergy Asthma Immunol. 2013 Dec; 111(6):567-8. View abstract
  197. Atopy and the development of chronic rhinosinusitis in children with allergic rhinitis. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):689-91.e1-2. View abstract
  198. Turning up the heat on skin testing for baked egg allergy. Clin Exp Allergy. 2013 Oct; 43(10):1095-6. View abstract
  199. Food allergy and increased asthma morbidity in a School-based Inner-City Asthma Study. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):479-84. View abstract
  200. Predictors of indoor exposure to mouse allergen in inner-city elementary schools. Ann Allergy Asthma Immunol. 2013 Oct; 111(4):299-301.e1. View abstract
  201. Environmental assessment and exposure reduction of cockroaches: a practice parameter. J Allergy Clin Immunol. 2013 Oct; 132(4):802-8.e1-25. View abstract
  202. Reply: To PMID 23687635. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):543-4. View abstract
  203. Ovomucoid is not superior to egg white testing in predicting tolerance to baked egg. J Allergy Clin Immunol Pract. 2013 Jul-Aug; 1(4):354-60. View abstract
  204. Xenon ventilation computed tomography rules: new technology may open up further understanding in asthma. Ann Allergy Asthma Immunol. 2013 Aug; 111(2):81. View abstract
  205. Climate change and our environment: the effect on respiratory and allergic disease. J Allergy Clin Immunol Pract. 2013 Mar; 1(2):137-41. View abstract
  206. Environmental assessment and exposure reduction of rodents: a practice parameter. Ann Allergy Asthma Immunol. 2012 Dec; 109(6):375-87. View abstract
  207. Obesity is not a risk factor for repeat epinephrine use in the treatment of anaphylaxis. J Allergy Clin Immunol. 2012 Nov; 130(5):1216-8. View abstract
  208. Predicting food challenge outcomes for baked milk: role of specific IgE and skin prick testing. Ann Allergy Asthma Immunol. 2012 Nov; 109(5):309-313.e1. View abstract
  209. The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma. 2012 Aug; 49(6):586-92. View abstract
  210. Allergens in urban schools and homes of children with asthma. Pediatr Allergy Immunol. 2012 Sep; 23(6):543-9. View abstract
  211. Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis. Allergy Asthma Proc. 2012 May-Jun; 33(3):282-8. View abstract
  212. Role of specific IgE and skin-prick testing in predicting food challenge results to baked egg. Allergy Asthma Proc. 2012 May-Jun; 33(3):275-81. View abstract
  213. Endotoxin exposure in inner-city schools and homes of children with asthma. Ann Allergy Asthma Immunol. 2012 Jun; 108(6):418-22. View abstract
  214. Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol. 2012 Apr; 108(4):223.e1-15. View abstract
  215. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012 Mar; 148(3):391-2. View abstract
  216. The school inner-city asthma study: design, methods, and lessons learned. J Asthma. 2011 Dec; 48(10):1007-14. View abstract
  217. Agreement between parent and student responses to an asthma and allergy questionnaire in a diverse, inner-city elementary school population. Ann Allergy Asthma Immunol. 2011 Oct; 107(4):371-3. View abstract
  218. Impact of environmental controls on childhood asthma. Curr Allergy Asthma Rep. 2011 Oct; 11(5):414-20. View abstract
  219. Characterizing the relationship between sesame, coconut, and nut allergy in children. Pediatr Allergy Immunol. 2010 Dec; 21(8):1114-8. View abstract
  220. Tree nut allergy, egg allergy, and asthma in children. Clin Pediatr (Phila). 2011 Feb; 50(2):133-9. View abstract
  221. The effect of prophylactic palivizumab on recurrent wheezing in children with an atopic family history. J Allergy Clin Immunol. 2011 Jan; 127(1):292-3; author reply 293. View abstract
  222. Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American Thoracic Society Guidelines. J Asthma. 2010 Sep; 47(7):762-7. View abstract
  223. The role of allergen exposure and avoidance in asthma. Adolesc Med State Art Rev. 2010 Apr; 21(1):57-71, viii-ix. View abstract
  224. Sublingual desensitization for buprenorphine hypersensitivity. J Allergy Clin Immunol. 2010 Apr; 125(4):938-9. View abstract
  225. Pest and allergen exposure and abatement in inner-city asthma: a work group report of the American Academy of Allergy, Asthma & Immunology Indoor Allergy/Air Pollution Committee. J Allergy Clin Immunol. 2010 Mar; 125(3):575-81. View abstract
  226. Age-specific prevalence of outdoor and indoor aeroallergen sensitization in Boston. Clin Pediatr (Phila). 2010 Jun; 49(6):579-85. View abstract
  227. Air filters and air cleaners: rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee. J Allergy Clin Immunol. 2010 Jan; 125(1):32-8. View abstract
  228. Sesame allergy: role of specific IgE and skin-prick testing in predicting food challenge results. Allergy Asthma Proc. 2009 Nov-Dec; 30(6):643-8. View abstract
  229. Skin Testing With Water Buffalo's Milk in Children With Cow's Milk Allergy. Pediatr Asthma Allergy Immunol. 2009 Sep; 22(3):121-125. View abstract
  230. Higher incidence of pediatric anaphylaxis in northern areas of the United States. J Allergy Clin Immunol. 2009 Oct; 124(4):850-2.e2. View abstract
  231. Tolerance to water buffalo milk in a child with cow milk allergy. Ann Allergy Asthma Immunol. 2009 Apr; 102(4):349. View abstract
  232. The role of indoor allergens in the development of asthma. Curr Opin Allergy Clin Immunol. 2009 Apr; 9(2):128-35. View abstract
  233. Mouse allergens in urban elementary schools and homes of children with asthma. Ann Allergy Asthma Immunol. 2009 Feb; 102(2):125-30. View abstract
  234. Sesame Allergy: Role of Specific IgE and Skin Prick Testing in Predicting Food Challenge Results. J Allergy Clin Immunol. 2009 Feb; 123(2 Suppl 1):S24. View abstract
  235. Montelukast as Monotherapy for Pediatric Asthma. MP Med Prakt Pediatr. 2009; 3(63):20-23. View abstract
  236. Cyclosporine Treatment of Intractable Colitis in Chronic Granulomatous Disease. Pediatr Asthma Allergy Immunol. 2009; 14(2):125-127. View abstract
  237. Mouse allergen exposure, wheeze and atopy in the first seven years of life. Allergy. 2008 Nov; 63(11):1512-8. View abstract
  238. Allergists' attitudes toward environmental control: insights into its current application in clinical practice. J Allergy Clin Immunol. 2008 Apr; 121(4):1053-4. View abstract
  239. Prevalence and titer of IgE antibodies to mouse allergens. J Allergy Clin Immunol. 2007 Nov; 120(5):1058-64. View abstract
  240. Sensitization to mouse allergen and asthma and asthma morbidity among women in Boston. J Allergy Clin Immunol. 2007 Oct; 120(4):954-6. View abstract
  241. Environmental factors and childhood asthma. Pediatr Ann. 2006 Sep; 35(9):646-56. View abstract
  242. Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test. Ann Allergy Asthma Immunol. 2006 Aug; 97(2):182-6. View abstract
  243. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children. Ann Allergy Asthma Immunol. 2006 May; 96(5):701-6. View abstract
  244. Treatment of glenoid loosening and bone loss due to osteolysis with glenoid bone grafting. J Shoulder Elbow Surg. 2006 Jan-Feb; 15(1):84-7. View abstract
  245. Allergens of animal and biological systems Chapter 12. Fleming DO, Hunt DL, editors. Biological safety: principles and practices. 2006. View abstract
  246. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005 Oct; 24(5):839-47. View abstract
  247. Predictors of indoor exposure to mouse allergen in urban and suburban homes in Boston. Allergy. 2005 May; 60(5):697-701. View abstract
  248. Mouse exposure and wheeze in the first year of life. Ann Allergy Asthma Immunol. 2005 May; 94(5):593-9. View abstract
  249. Allergic rhinoconjunctivitis: epidemiology. Immunol Allergy Clin North Am. 2005 May; 25(2):263-81, vi. View abstract
  250. Low-normal gestational age as a predictor of asthma at 6 years of age. Pediatrics. 2004 Sep; 114(3):e327-32. View abstract
  251. Endotoxin exposure and eczema in the first year of life. Pediatrics. 2004 Jul; 114(1):13-8. View abstract
  252. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004 Apr; 92(4):420-5. View abstract
  253. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003 Jul; 91(1):49-54. View abstract
  254. Churg-Strauss syndrome in a 7-year-old receiving montelukast and inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003 Feb; 90(2):274. View abstract
  255. Environmental indoor allergens. Pediatr Ann. 2003 Jan; 32(1):40-8. View abstract
  256. Rodent allergens. Curr Allergy Asthma Rep. 2002 Sep; 2(5):412-6. View abstract
  257. The efficacy of montelukast in the treatment of cat allergen-induced asthma in children. J Allergy Clin Immunol. 2002 May; 109(5):794-9. View abstract
  258. Animal allergens and their control. Curr Allergy Asthma Rep. 2001 Sep; 1(5):461-5. View abstract
  259. Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency. Clin Infect Dis. 2001 Jan; 32(1):E13-4. View abstract
  260. Mouse allergen. I. The prevalence of mouse allergen in inner-city homes. The National Cooperative Inner-City Asthma Study. J Allergy Clin Immunol. 2000 Dec; 106(6):1070-4. View abstract
  261. Mouse allergen. II. The relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in inner-city children with asthma. J Allergy Clin Immunol. 2000 Dec; 106(6):1075-80. View abstract
  262. A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. J Allergy Clin Immunol. 2000 Apr; 105(4):704-10. View abstract
  263. Vomiting and syncope in a 14-year-old female. Ann Allergy Asthma Immunol. 2000 Mar; 84(3):290-3. View abstract
  264. Cyclosporine treatment of intractable colitis in chronic granulomatous disease. Pediatr Asthma Allergy Immunol. 2000; 14(2):125-8. View abstract
  265. Allergens of animal and biological systems. Fleming DO, Hunt DL, editors. Biological safety: principles and practices. 2000; 249-59. View abstract
  266. “Cross-reactivity between sulfonamides and loop or thiazide diuretics: Is it a theoretical or actual risk?”. Allergy Clin Immunol International. 2000; 12:26-28. View abstract
  267. Cross-Reactivity Between Sulfonamides and Loop or Thiazide Diuretics: Is it a Theoretical or Actual Risk? Allergy Clin Immunol Int. 2000; 12(1):26-28. View abstract
  268. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999 May; 103(5 Pt 1):773-9. View abstract
  269. The value of acoustic rhinometry in assessing nasal responses to cat exposure. J Allergy Clin Immunol. 1998 Dec; 102(6 Pt 1):896-901. View abstract
  270. The fallacy of evaluating biomaterial wear-rates with water as lubricant: a hip simulator study of alumina-PTFE nd CoCr-PTFE combinations. J Biomed Mater Res. 1998 Feb; 39(2):229-33. View abstract